“Extended Half-Life RFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective”. 2020. Farmeconomia. Health Economics and Therapeutic Pathways 21 (1). https://doi.org/10.7175/fe.v21i1.1472.